Role of C-reactive protein in urological cancers: A useful biomarker for predicting outcomes

Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score

(2011) Georgios Gakis et al.   BJU INTERNATIONAL

A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study

(2011) Michael J. Proctor et al.   EUROPEAN JOURNAL OF CANCER

High-Sensitivity C-Reactive Protein and Cancer

(2011) Seounghee Lee et al.   JOURNAL OF EPIDEMIOLOGY

Impact of Postoperative C-Reactive Protein Level on Recurrence and Prognosis in Patients With N0M0 Clear Cell Renal Cell Carcinoma

(2011) Keiichi Ito et al.   JOURNAL OF UROLOGY

Intratumor C-Reactive Protein as a Biomarker of Prognosis in Localized Renal Cell Carcinoma

(2011) T.V. Johnson et al.   JOURNAL OF UROLOGY

Prognostic Impact of C-reactive Protein for Determining Overall Survival of Patients With Castration-resistant Prostate Cancer Treated With Docetaxel

(2011) Masaya Ito et al.   UROLOGY

Phase-II trial of combination treatment of interferon-α, cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin-system inhibitor (I-CCA therapy) for advanced renal cell carcinoma

(2010) Manabu Tatokoro et al.   CANCER SCIENCE

Immunity, Inflammation, and Cancer

(2010) Sergei I. Grivennikov et al.   CELL

C-reactive protein; a potential marker of second cancer and cardiovascular disease in testicular cancer survivors?

(2010) T. Wethal et al.   EUROPEAN JOURNAL OF CANCER

Role of C-reactive protein as a biomarker for renal cell carcinoma

(2010) Kazutaka Saito et al.   Expert Review of Anticancer Therapy

Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammation

(2010) Mieke Van Hemelrijck et al.   INTERNATIONAL JOURNAL OF CANCER

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials

(2010) Peter M Rothwell et al.   LANCET

Systemic Inflammatory Response and Survival in Patients with Localised Prostate Cancer: 10-Year Follow-Up

(2010) Peter A. McArdle et al.   UROLOGIA INTERNATIONALIS

C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): Confirmatory results

(2010) Renee C. Prins et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Postoperative Better Than Preoperative C-reactive Protein at Predicting Outcome After Potentially Curative Nephrectomy for Renal Cell Carcinoma

(2010) T.V. Johnson et al.   UROLOGY

An Integrated View of Humoral Innate Immunity: Pentraxins as a Paradigm

(2009) Barbara Bottazzi et al.   Annual Review of Immunology

Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue

(2009) Ingrid J. Orre et al.   BRAIN BEHAVIOR AND IMMUNITY

Prognosis of Japanese Metastatic Renal Cell Carcinoma Patients in the Cytokine Era: A Cooperative Group Report of 1463 Patients

(2009) Sei Naito et al.   EUROPEAN UROLOGY

Role of systemic inflammatory response in predicting survival in patients with primary operable cancer

(2009) Campbell SD Roxburgh et al.   Future Oncology

Multicenter Phase II Trial of Combination Therapy with Meloxicam, a COX-2 Inhibitor, and Natural Interferon-  for Metastatic Renal Cell Carcinoma

(2009) N. Shinohara et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Development and External Validation of a New Outcome Prediction Model for Patients With Clear Cell Renal Cell Carcinoma Treated With Nephrectomy Based on Preoperative Serum C-Reactive Protein and TNM Classification: The TNM-C Score

(2009) Yasumasa Iimura et al.   JOURNAL OF UROLOGY

Absolute Preoperative C-Reactive Protein Predicts Metastasis and Mortality in the First Year Following Potentially Curative Nephrectomy for Clear Cell Renal Cell Carcinoma

(2009) T.V. Johnson et al.   JOURNAL OF UROLOGY

C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy

(2008) Soichiro Yoshida et al.   BJU INTERNATIONAL

Prospective study of the relationship between the systemic inflammatory response, prognostic scoring systems and relapse-free and cancer-specific survival in patients undergoing potentially curative resection for renal cancer

(2008) Sara Ramsey et al.   BJU INTERNATIONAL

C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer

(2008) Tomasz M. Beer et al.   CANCER

Impact of C-Reactive Protein Kinetics on Survival of Patients with Metastatic Renal Cell Carcinoma

(2008) Kazutaka Saito et al.   EUROPEAN UROLOGY

Prognostic Impact of Postoperative C-Reactive Protein Level in Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy

(2008) Manabu Tatokoro et al.   JOURNAL OF UROLOGY

Cancer-related inflammation

(2008) Alberto Mantovani et al.   NATURE

An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer

(2008) Donald C. McMillan   PROCEEDINGS OF THE NUTRITION SOCIETY

Simple Stratification of Survival Using Bone Scan and Serum C-Reactive Protein in Prostate Cancer Patients with Metastases

(2008) Jun Nakashima et al.   UROLOGIA INTERNATIONALIS

Clinical outcome of combined immunotherapy with interferon-α and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma

(2008) Hideaki Miyake et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS